Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy

Journal of Hepatology

Volumn 52, Issue 6, 2010, Pages 812-816

  Hofer, Harald ^a   Donnerer, Josef ^b   Sator, Kathrin ^a   Staufer, Katharina ^a   Scherzer, Thomas Matthias ^a   Dejaco, Clemens ^a   Sator, Michael ^a   Kessler, Harald ^b   Ferenci, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Antiviral therapy; Chronic hepatitis C; Hepatitis C virus; Ribavirin; Seminal fluid

Indexed keywords

PEGINTERFERON ALPHA2A; RIBAVIRIN; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; ASTHENOSPERMIA; ASTHENOTERATOZOOSPERMIA; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEMEN ANALYSIS; SEMINAL PLASMA; SIDE EFFECT; SPERMATOZOON; SPERMATOZOON ABNORMALITY; SPERMATOZOON DENSITY; SPERMATOZOON MORPHOLOGY; SPERMATOZOON MOTILITY; TERATOZOOSPERMIA; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; ASTHENOZOOSPERMIA; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; MALE; MIDDLE AGED; OLIGOSPERMIA; RIBAVIRIN; RNA, VIRAL; SEMEN; SPERMATOGENESIS; SPERMATOZOA;

EID: 77952427109     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.12.039     Document Type: Article

References (25)

1. Morris D.J. Adverse effects and drug interactions of clinical importance with antiviral drugs. Drug Saf 10 (1994) 281-291
2. Kochhar D.M., Penner J.D., and Knudsen T.B. Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice. Toxicol Appl Pharmacol 52 (1980) 99-112
3. Narayana K., D́Souza U.J., and Rao K.P. Effect of ribavirin on epididymal sperm count in rat. Indian J Physiol Pharmacol 46 (2002) 97-101
4. Narayana K., D'Souza U.J., and Seetharama Rao K.P. Ribavirin-induced sperm shape abnormalities in Wistar rat. Mutat Res 513 (2002) 193-196
5. Levine B.S., Tomlinson M.J., and Parker R.M. Onset and reversibility of ribavirin-induced testicular toxicity in mice. Toxic Subst J 13 (1994) 171-186
6. Hegenbarth K., Maurer U., Kroisel P.M., Fickert P., Trauner M., and Stauber R.E. No evidence for mutagenic effects of ribavirin: report of two normal pregnancies. Am J Gastroenterol 96 (2001) 2286-2287
7. Wejstal R. Sexual transmission of hepatitis C virus. J Hepatol 31 (1999) 92-95
8. Halfon P., Riflet H., Renou C., Quentin Y., and Cacoub P. Molecular evidence of male-to-female sexual transmission of hepatitis C virus after vaginal and anal intercourse. J Clin Microbiol 39 (2001) 1204-1206
9. Debono E., Halfon P., Bourliere M., Gerolami-Santandrea V., Gastaldi M., Castellani P., et al. Absence of hepatitis C genome in semen of infected men by polymerase chain reaction, branched DNA and in situ hybridization. Liver 20 (2000) 257-261
10. Briat A., Dulioust E., Galimand J., Fontaine H., Chaix M.L., Letur-Konirsch H., et al. Hepatitis C virus in the semen of men coinfected with HIV-1: prevalence and origin. AIDS 19 (2005) 1827-1835
11. Fried M.W., Shindo M., Fong T.L., Fox P.C., Hoofnagle J.H., and Di Bisceglie A.M. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology 102 (1992) 1306-1308
12. Semprini A.E., Persico T., Thiers V., Oneta M., Tuveri R., Serafini P., et al. Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men. J Infect Dis 177 (1998) 848-854
13. Liou T.C., Chang T.T., Young K.C., Lin X.Z., Lin C.Y., and Wu H.L. Detection of HCV RNA in saliva, urine, seminal fluid, and ascites. J Med Virol 37 (1992) 197-202
14. Leruez-Ville M., Kunstmann J.M., de Almeida M., Rouzioux C., and Chaix M.L. Detection of hepatitis C virus in the semen of infected men. Lancet 356 (2000) 42-43
15. Pasquier C., Bujan L., Daudin M., Righi L., Berges L., Thauvin L., et al. Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV. J Med Virol 69 (2003) 344-349
16. Bourlet T., Levy R., Maertens A., Tardy J.C., Grattard F., Cordonier H., et al. Detection and characterization of hepatitis C virus RNA in seminal plasma and spermatozoon fractions of semen from patients attempting medically assisted conception. J Clin Microbiol 40 (2002) 3252-3255
17. Pekler V.A., Robbins W.A., Nyamathi A., Yashina T.L., Leak B., and Robins T.A. Use of versant TMA and bDNA 30 assays to detect and quantify hepatitis C virus in semen. J Clin Lab Anal 17 (2003) 264-270
18. Browne R., Asboe D., Gilleece Y., Atkins M., Mandalia S., Gazzard B., et al. Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase?. Sex Transm Infect 80 (2004) 326-327
19. Rauch A., Rickenbach M., Weber R., Hirschel B., Tarr P.E., Bucher H.C., et al. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clin Infect Dis 41 (2005) 395-402
20. Durazzo M., Premoli A., Di Bisceglie C., Bertagna A., Faga E., Biroli G., et al. Alterations of seminal and hormonal parameters: an extrahepatic manifestation of HCV infection?. World J Gastroenterol 12 (2006) 3073-3076
21. Ferenci P., Laferl H., Scherzer T.M., Gschwantler M., Maieron A., Brunner H., et al. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response. Gastroenterology 135 (2008) 451-458
22. Ferenci P., Brunner H., Laferl H., Scherzer T.M., Maieron A., Strasser M., et al. A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3. Hepatology 47 (2008) 1816-1823
23. Svensson J.O., Bruchfeld A., Schvarcz R., and Ståhle L. Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography. Ther Drug Monit 22 (2000) 215-218
24. Donnerer J., Grahovac M., Stelzl E., Kessler H.H., Bankuti C., Stadlbauer V., et al. Ribavirin levels and haemoglobin decline in early virological responders and non-responders to hepatitis C virus combination therapy. Pharmacology 76 (2006) 136-140
25. Pecou S., Moinard N., Walschaerts M., Pasquier C., Daudin M., and Bujan L. Ribavirin and pegylated Interferon treatment for hepatitis C was associated not only with semen alterations but also with sperm deoxyribonucleic acid fragmentation in humans. Fertil Steril 91 (2009) 933.e17-933.e22